Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 12-2017 | |
| Sales | 11,568 | 0 |
| Cost of Goods | 5,044 | N/A |
| Gross Profit | 6,524 | N/A |
| Operating Expenses | 19,881 | 0 |
| Operating Income | -13,313 | N/A |
| Other Income | 820 | 0 |
| Pre-tax Income | -12,493 | 0 |
| Net Income Continuous | -12,493 | N/A |
| Net Income | $-12,493 | $N/A |
| EPS Basic Total Ops | -1.01 | N/A |
| EPS Basic Continuous Ops | -1.01 | N/A |
| EPS Diluted Total Ops | -1.01 | N/A |
| EPS Diluted Continuous Ops | -1.01 | N/A |
| EBITDA(a) | $-13,313 | $N/A |